These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1923910)

  • 21. Pharmacokinetic variability of nimodipine disposition after single and multiple oral dosing to hypertensive renal failure patients: parametric and nonparametric population analysis.
    Terziivanov D; Atanasova I; Dimitrova V; Robeva R; Unger S; Mück W
    Int J Clin Pharmacol Ther; 1999 Aug; 37(8):404-12. PubMed ID: 10475143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacokinetic modeling of steady state carbamazepine clearance in children, adolescents, and adults.
    Reith DM; Hooper WD; Parke J; Charles B
    J Pharmacokinet Pharmacodyn; 2001 Feb; 28(1):79-92. PubMed ID: 11253616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of salivary drug monitoring for detecting efflux transporter overexpression.
    Fagiolino P; Vázquez M; Maldonado C; Ruiz ME; Volonté MG; Orozco-Suárez S; Lazarowski A
    Curr Pharm Des; 2013; 19(38):6701-8. PubMed ID: 23530513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors influencing carbamazepine pharmacokinetics in children and adults: population pharmacokinetic analysis.
    Milovanovic JR; Jankovic SM
    Int J Clin Pharmacol Ther; 2011 Jul; 49(7):428-36. PubMed ID: 21726493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbamazepine population pharmacokinetics in children: mixed-effect models.
    Delgado Iribarnegaray MF; Santo Bueldga D; García Sánchez MJ; Otero MJ; Falcão AC; Domínguez-Gil A
    Ther Drug Monit; 1997 Apr; 19(2):132-9. PubMed ID: 9108639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A model for the determination of carbamazepine clearance in children on mono- and polytherapy.
    Gray AL; Botha JH; Miller R
    Eur J Clin Pharmacol; 1998 Jun; 54(4):359-62. PubMed ID: 9696965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetic profile of carbamazepine in an adult Portuguese outpatient population.
    Almeida AM; Falcão AC; Sales F; Leitão F; Santos J; Costa IM; Caramona MM
    J Clin Pharm Ther; 1998 Aug; 23(4):315-21. PubMed ID: 9867316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iron supplements in nursing home patients associated with reduced carbamazepine absorption.
    Ahn JE; Bathena SPR; Brundage RC; Conway JM; Leppik IE; Birnbaum AK
    Epilepsy Res; 2018 Nov; 147():115-118. PubMed ID: 30327119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic study of carbamazepine and its epoxide metabolite in humans.
    Sumi M; Watari N; Umezawa O; Kaneniwa N
    J Pharmacobiodyn; 1987 Nov; 10(11):652-61. PubMed ID: 3446773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioavailability of controlled release carbamazepine estimated by mixed effect modelling.
    Miller R; Ludden TM
    Eur J Clin Pharmacol; 1993; 44(3):231-5. PubMed ID: 8491236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Memantine pharmacotherapy: a naturalistic study using a population pharmacokinetic approach.
    Kornhuber J; Kennepohl EM; Bleich S; Wiltfang J; Kraus T; Reulbach U; Meineke I
    Clin Pharmacokinet; 2007; 46(7):599-612. PubMed ID: 17596105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimation of population pharmacokinetics for carbamazepine in Malaysian patients using the OPT computer program.
    Ismail R; Rahman AF
    J Clin Pharm Ther; 1993 Feb; 18(1):55-8. PubMed ID: 8473361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population pharmacokinetics of haloperidol using routine clinical pharmacokinetic data in Japanese patients.
    Yukawa E; Hokazono T; Yukawa M; Ichimaru R; Maki T; Matsunaga K; Ohdo S; Anai M; Higuchi S; Goto Y
    Clin Pharmacokinet; 2002; 41(2):153-9. PubMed ID: 11888334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacoepidemiologic investigation of a clonazepam-carbamazepine interaction by mixed effect modeling using routine clinical pharmacokinetic data in Japanese patients.
    Yukawa E; Nonaka T; Yukawa M; Ohdo S; Higuchi S; Kuroda T; Goto Y
    J Clin Psychopharmacol; 2001 Dec; 21(6):588-93. PubMed ID: 11763006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of body size on the metabolic clearance of carbamazepine.
    Reith DM; Appleton DB; Hooper W; Eadie MJ
    Biopharm Drug Dispos; 2000 Apr; 21(3):103-11. PubMed ID: 11113883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absolute bioavailability of carbamazepine after oral administration of a 2% syrup.
    Gérardin A; Dubois JP; Moppert J; Geller L
    Epilepsia; 1990; 31(3):334-8. PubMed ID: 2344850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of enteral tube feeding on the absorption and pharmacokinetic profile of carbamazepine suspension.
    Bass J; Miles MV; Tennison MB; Holcombe BJ; Thorn MD
    Epilepsia; 1989; 30(3):364-9. PubMed ID: 2498074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between systemic drug absorption and gastrointestinal transit after the simultaneous oral administration of carbamazepine as a controlled-release system and as a suspension of 15N-labelled drug to healthy volunteers.
    Wilding IR; Davis SS; Hardy JG; Robertson CS; John VA; Powell ML; Leal M; Lloyd P; Walker SM
    Br J Clin Pharmacol; 1991 Nov; 32(5):573-9. PubMed ID: 1954073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lithium population pharmacokinetics from routine clinical data: role of patient characteristics for estimating dosing regimens.
    Yukawa E; Nomiyama N; Higuchi S; Aoyama T
    Ther Drug Monit; 1993 Apr; 15(2):75-82. PubMed ID: 8503142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic interactions between carbamazepine and the traditional Chinese medicine Paeoniae Radix.
    Chen LC; Chen YF; Chou MH; Lin MF; Yang LL; Yen KY
    Biol Pharm Bull; 2002 Apr; 25(4):532-5. PubMed ID: 11995940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.